Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
What is the Endocrine System?00:46

What is the Endocrine System?

The endocrine system sends hormones—chemical signals—through the bloodstream to target cells—the cells the hormones selectively affect. These signals are produced in endocrine cells, secreted into the extracellular fluid, and then diffuse into the blood. Eventually, they diffuse out of the blood and bind to target cells which have specialized receptors to recognize the hormones.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oxidative DNA damage in reconstituting T cells is associated with relapse and inferior survival after allo-SCT.

Blood·2022
Same author

Mental health improvements after elective spine surgery: a Canadian Spine Outcome Research Network (CSORN) study.

The spine journal : official journal of the North American Spine Society·2021
Same author

Clinical and molecular characteristics and treatment outcomes of advanced right-colon, left-colon and rectal cancers: data from 1180 patients in a phase III trial of panitumumab with an extended biomarker panel.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Search for direct top squark pair production in final states with two leptons in <math> </math> TeV <i>pp</i> collisions with the ATLAS detector.

The European physical journal. C, Particles and fields·2020
Same author

Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector.

Scientific reports·2019
Same author

Observation of Electroweak Production of a Same-Sign W Boson Pair in Association with Two Jets in pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2019

Related Experiment Video

Updated: Jul 1, 2026

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

Cellular therapies in endocrine diseases.

C Papewalis1, B Jacobs, M Wuttke

  • 1Department of Endocrinology, Diabetes and Rheumatology, University Hospital Duesseldorf, Duesseldorf, Germany. claudia.papewalis@uni-duesseldorf.de

Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|October 23, 2008
PubMed
Summary

Advances in cellular therapy offer new hope for treating endocrine cancers and re-establishing immune tolerance in autoimmune diseases. Research explores novel immune mechanisms and stem cell applications for future treatments.

More Related Videos

Positron Emission Tomography Imaging of Cell Trafficking: A Method of Cell Radiolabeling
10:07

Positron Emission Tomography Imaging of Cell Trafficking: A Method of Cell Radiolabeling

Published on: October 27, 2023

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

Related Experiment Videos

Last Updated: Jul 1, 2026

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

Positron Emission Tomography Imaging of Cell Trafficking: A Method of Cell Radiolabeling
10:07

Positron Emission Tomography Imaging of Cell Trafficking: A Method of Cell Radiolabeling

Published on: October 27, 2023

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

Area of Science:

  • Immunology
  • Oncology
  • Endocrinology
  • Autoimmune Diseases

Background:

  • Limited curative therapies exist for many malignant and autoimmune diseases.
  • Significant progress in understanding immunity and immune tolerance over the past two decades.
  • Identification of immune mechanisms that break tolerance and induce cytotoxic immunity.

Purpose of the Study:

  • To review current advances in cellular therapy for endocrine cancers.
  • To discuss strategies for re-inducing immune tolerance in autoimmune diseases.
  • To present new insights into stem cell research for autoimmune disorders and outline future perspectives.

Main Methods:

  • Review of recent scientific literature on cellular therapy, immunology, and stem cell research.
  • Synthesis of findings related to immune mechanisms in cancer and autoimmunity.
  • Exploration of emerging therapeutic strategies.

Main Results:

  • Progress in identifying immune mechanisms underlying disease states.
  • Development of cellular therapies for endocrine cancers.
  • Advancements in understanding and re-inducing immune tolerance for autoimmune conditions.
  • Emerging role of stem cell research in autoimmune disease treatment.

Conclusions:

  • Cellular therapies show promise for endocrine cancers.
  • Re-inducing immune tolerance is a key strategy for autoimmune diseases.
  • Stem cell research offers new avenues for treating autoimmune disorders.
  • Continued research is crucial for future therapeutic advancements.